HIV virological non-suppression is highly prevalent among 18-to 24-year-old youths on antiretroviral therapy at the Kenyan coast
MK Nyongesa, MH Mwatasa, VA Kagonya… - BMC Infectious …, 2022 - Springer
Abstract Background In sub-Saharan Africa, data on virologic outcomes of young people
living with HIV (YLWH) enrolled on antiretroviral therapy (ART) remains scarce. In this study …
living with HIV (YLWH) enrolled on antiretroviral therapy (ART) remains scarce. In this study …
High prevalence of transmitted antiretroviral drug resistance among newly HIV type 1 diagnosed adults in Mombasa, Kenya
KCE Sigaloff, K Mandaliya, RL Hamers… - AIDS research and …, 2012 - liebertpub.com
In view of the recent antiretroviral therapy (ART) scale-up in Kenya, surveillance of
transmitted HIV drug resistance (TDR) is important. A cross-sectional survey was conducted …
transmitted HIV drug resistance (TDR) is important. A cross-sectional survey was conducted …
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa
VC Marconi, H Sunpath, Z Lu, M Gordon… - Clinical infectious …, 2008 - academic.oup.com
Background. Emergence of human immunodeficiency virus type 1 (HIV-1) drug resistance
may limit the benefits of antiretroviral therapy in resource-limited settings. The prevalence of …
may limit the benefits of antiretroviral therapy in resource-limited settings. The prevalence of …
A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial
… European Network for the Treatment of AIDS … - Antiviral …, 2006 - journals.sagepub.com
Objective To evaluate the longer-term utility of genotypic resistance testing in HIV-1-infected
children with virological failure. Methods Children aged 3 months-18 years switching …
children with virological failure. Methods Children aged 3 months-18 years switching …
Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda
V Musiime, J Kayiwa, M Kiconco, W Tamale… - AIDS research and …, 2012 - liebertpub.com
From 2006 to 2011, a cohort study was conducted among 1000 children resident in urban
and rural settings of Uganda to ascertain and compare the response to antiretroviral therapy …
and rural settings of Uganda to ascertain and compare the response to antiretroviral therapy …
Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy
DC Wamalwa, DA Lehman… - JAIDS Journal of …, 2013 - journals.lww.com
Background: HIV-infected children may require the use of combination antiretroviral
treatment (cART) into adulthood. However, regimens are limited to first line and second line …
treatment (cART) into adulthood. However, regimens are limited to first line and second line …
Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda
Few reports have examined the impact of HIV-1 transmitted drug resistance (TDR) in
resource-limited settings where there are fewer regimen choices and limited pretherapy …
resource-limited settings where there are fewer regimen choices and limited pretherapy …
Trends in genotypic HIV-1 antiretroviral resistance between 2006 and 2012 in South African patients receiving first-and second-line antiretroviral treatment regimens
Objectives South Africa's national antiretroviral (ARV) treatment program expanded in 2010
to include the nucleoside reverse transcriptase (RT) inhibitors (NRTI) tenofovir (TDF) for …
to include the nucleoside reverse transcriptase (RT) inhibitors (NRTI) tenofovir (TDF) for …
High levels of dual-class drug resistance in HIV-infected children failing first-line antiretroviral therapy in Southern Ethiopia
BT Tadesse, NN Kinloch, B Baraki, HR Lapointe… - Viruses, 2018 - mdpi.com
Clinical monitoring of pediatric HIV treatment remains a major challenge in settings where
drug resistance genotyping is not routinely available. As a result, our understanding of drug …
drug resistance genotyping is not routinely available. As a result, our understanding of drug …
Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda
JA Ndahimana, DJ Riedel… - Tropical Medicine & …, 2016 - Wiley Online Library
Objective To evaluate HIV drug resistance (HIVDR) and determinants of virological failure in
a large cohort of patients receiving first‐line tenofovir‐based antiretroviral therapy (ART) …
a large cohort of patients receiving first‐line tenofovir‐based antiretroviral therapy (ART) …